2m 2m 2m 2m 2m 2m 2m
CRINETICS PHARMA (CRNX)
NASDAQ
$84.69-$0.005 (-0.006%)
Price as of Aug 21, 2026 7:30 PM EDT- $9.0BMarket Cap
- 173.90%1-Year Change
- BiotechnologyIndustry
CRINETICS PHARMA (CRNX)
$84.69-$0.005 (-0.006%)
CRNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $84.69 | ||
Change | $0.00 (0.00%) | ||
Open | $84.70 | ||
High | $84.77 | ||
Low | $84.69 | ||
Previous Close | $84.69 | ||
Volume | 2,016,688 | ||
30-Day Average Volume | 2,814,238 | ||
1-Week Change | -0.01% | ||
1-Month Change | 0.94% | ||
1-Year Change | 173.90% | ||
3-Year Change | 427.66% | ||
5-Year Change | 305.80% | ||
Fundamentals | |||
Shares Outstanding | 106.1M | ||
Total Assets | $1.3B | ||
Market Cap | $9.0B | ||
Enterprise Value | $8.9B | ||
Period: QTR TTM FY | |||
Revenue | $24.0M | ||
Net Income | -$120.9M | ||
Free Cash Flow | -$94.7M | ||
EBIT | -$120.9M | ||
EBITDA | -$119.8M | ||
Net Working Capital | $1.2B | ||
EPS | -$1.14 | ||
Enterprise Value/EBITDA | -75 | ||
Enterprise Value/Revenue | 371 | ||
P/B | 8 | ||
P/E | -74 | ||
PEG | -10 | ||
Price/Free Cash Flow | -95 | ||
Price/Operating Cash Flow | -95 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue